RSNA 2014 

Abstract Archives of the RSNA, 2014


GIE023-b

Multimodality Imaging of Inmunotheraphy: What Every General Radiologist Should Know

Education Exhibits

Presented in 2014

Participants

Angela Patricia Moreno MD, Presenter: Nothing to Disclose
Jorge Andres Abreu MD, Abstract Co-Author: Nothing to Disclose
Carolina Rumie Valois, Abstract Co-Author: Nothing to Disclose
Andres Vasquez MD, Abstract Co-Author: Nothing to Disclose
Juliana Ocampo MD, Abstract Co-Author: Nothing to Disclose
Javier Andres Romero MD, Abstract Co-Author: Nothing to Disclose

TEACHING POINTS

1.Response Criteria in Solid Tumors or WHO criteria, designed to detect early effects of cytotoxic agents, may not provide a complete assessment of immunotherapeutic agents; 2. The appearance of measurable antitumor activity may take longer for immune therapies than for cytotoxic therapies; 3. Iplimumab monotheraphy has four distinct patterns of tumor response: a. shrinkage in baseline lesions, without new lesions; b. durable stable disease with no significant change in the size of the baseline lesions (in some patients followed by slow, steady decline in total tumor burden); c. Response after an increase in total tumor burden; and d. response in the presence of new lesions;  4. Iplimumab produces a spectrum of immune-related adverse effects: enterocolitis, hypophysitis, hepatitis, dermatitis, myopathy, pancreatitis and nephritis; 6. Specific patterns of immune-related adverse events that are detectable radiologically should be recognized early and communicated to the clinician

TABLE OF CONTENTS/OUTLINE

Introduction Why not RECIST or WHO criteria? New criteria in the assessment of Immune related tumor response Types of response. Main differences with RECIST. Are they related with favorable survival? Adverse effects related with therapy. They can be recognized radiologically? Importance in the treatment surveillance. Conclusions.  

PDF UPLOAD

http://abstract.rsna.org/uploads/2014/14019348/14019348_h99p.pdf

Cite This Abstract

Moreno, A, Abreu, J, Rumie Valois, C, Vasquez, A, Ocampo, J, Romero, J, Multimodality Imaging of Inmunotheraphy: What Every General Radiologist Should Know.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14019348.html